Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Renal Denervation Devices Market – Easy Administration of Medications

Renal denervation devices play a major role in modern healthcare and are used in treatment of uncontrolled or persistent hypertension, where hypertensive medication is ineffective. The procedure consists of a catheter that emits radiofrequency energy across multiple electrodes.

The global renal denervation devices market size was valued at US$ 88.6 million in 2017, and is expected to exhibit a CAGR of 35.5% over the forecast period (2018 – 2026).

Figure 1. Global Renal Denervation Devices Market Value (US$ Mn), by Region, 2017

Renal Denervation Devices  | Coherent Market Insights

                                                                 Source: Coherent Market Insights Analysis (2019)

Increasing prevalence of hypertension is expected to propel growth of the renal denervation devices market

Increasing prevalence of cardiovascular diseases (CVDs) and hypertension is expected to drive demand for renal denervation devices worldwide. For instance, according to the World Health Organization (WHO), the prevalence of hypertension in adults aged 25 and above was around 40% in 2008 worldwide. According to the American College of Cardiology (ACC)/the American Heart Association (AHA), the clinical practice guidelines of hypertension have modified the definition of hypertension, which has increased the prevalence of hypertension to 45.6% or around 103.3 million people in U.S. in 2017.

Furthermore, according to WHO 2017, Africa accounts for the highest number of high blood pressure cases worldwide, affecting around 46% of adults, owing to increasing urbanization and unhealthy lifestyles. According to the Blood Pressure Association in the U.K., the highest number of people suffering from high blood pressure was recorded in South Asia and parts of Africa, where over 50% of those with high blood pressure lived in Asia Pacific, including 226 million people in China and 199 million in India in 2015. Therefore, increasing number of high blood pressure cases is expected to boost the market growth.

However, adoption of pharmaceutical therapy for the management of hypertension is expected to limit adoption of renal denervation devices, thereby hindering the market growth. For instance, according to American College of Cardiology (ACC)/American Heart Association (AHA), the number of people adopting pharmaceutical therapy increased by 13.9 million (from 24.0 in 2013 % to 54.4% of the treated patients) in the U.S. in 2017. Moreover, around 30 million people in China choose pharmaceutical treatment for hypertension in 2017.

Figure 2. Global Renal Denervation Device Market Share (%), by Products, 2018 and 2026

Renal Denervation Devices  | Coherent Market Insights

                                                               Source: Coherent Market Insights Analysis (2019)

Increasing research and development activities and regulatory approvals in Europe is expected to bolster the market growth

Europe holds dominant position in the global renal denervation device market, owing to increasing research and development activities and regulatory approvals. For instance, in February 2014, Cordis Corporation, a division of Johnson & Johnson, received CE Mark for Renlane renal denervation system. The system consists of a unique, helical shaped, irrigated, multi-electrode ablation catheter with a multi-channel radiofrequency (RF) ablation system.

Moreover, increasing number of clinical trials on renal denervation devices is also expected to boost the market growth. For instance, multi-center, international, single-blind, randomized, sham-controlled clinical trials of RADIANCE-HTN SOLO were conducted at 21 centers in the U.S. and 18 in Europe. The trials meet primary efficacy endpoint, according to an announcement by ReCor Medical in May 2018.

Key Players

Major players operating in the global renal denervation device market include, St. Jude Medical, Inc., ReCor Medical Inc., Boston Scientific Corporation, Cardiosonic Ltd, Medtronic Plc., Kona Medical, Inc., Mercator Medsystems, Inc., Terumo Corporation, Abbott Laboratories, and Theragenics Corporation.

Renal denervation is a catheter-based minimally-invasive procedure. It is a therapy performed by radiofrequency or ultrasound ablation for uncontrolled hypertension. Renal denervation is performed through endovascular catheter-based procedure to treat hypertension, which is beyond medication control. The procedure consists of a catheter that emits radiofrequency energy across multiple electrodes. Radiofrequency pulse is applied to the renal artery, which causes the wall of artery to ablate, reducing the nerve activity, thereby reducing blood pressure. The progress of catheter-based interventional therapies has yielded impressive results in certifying enhanced blood pressure control in patients with complaints of uncontrolled hypertension, vascular, and cardiovascular diseases.

Market Dynamics

Increasing prevalence of hypertension is a major factor driving renal denervation device market growth. According to the World Health Organization (WHO), the prevalence of high blood pressure in adults aged 25 and above was around 40% in 2008 and number of people with uncontrolled hypertension increased from 600 million in 1980 to around 1 billion in 2008. According to Fourth National Family Health Survey hypertension led to 1.63 million deaths in India in 2016 as compared to 0.78 million in 1990 and hypertension increased from 21 million in 1990 to 39 million in 2016.

Moreover, effective treatment through minimally-invasive catheter-based endovascular procedure is also expected to be drive growth of the market. For instance in 2013, U.S. FDA approved Symplicity HTN-4 renal denervation device. The device offers targeted radiofrequency energy delivery and minimizes the potential threat to surrounding tissues.

Key features of the study:

  • This report provides in-depth analysis of the renal denervation devices market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global renal denervation devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include St. Jude Medical, Inc., ReCor Medical Inc., Boston Scientific Corporation, Cardiosonic Ltd, Medtronic Plc., Kona medical, Inc., Mercator Medsystems, Inc., Terumo Corporation, Abbott Laboratories, and Theragenics Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global renal denervation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the renal denervation devices market

Detailed Segmentation:

  • Global Renal Denervation Devices Market, By Product Type:
    • Simplicity Renal Denervation System
    • Vessix Renal denervation System
    • EnligHTN
    • Paradise Renal Denervation System
    • Iberis Renal Sympathetic Denervation System
    • Others
  • Global Renal Denervation Devices Market, By Technology:
    • Radiofrequency
    • Ultrasound
  • Global Renal Denervation Devices Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Others
  • Global Renal Denervation Devices Market, By Geography:
    • North America
      • By Product Type:
        • Simplicity Renal Denervation System
        • Vessix Renal denervation System
        • EnligHTN
        • Paradise Renal Denervation System
        • Iberis Renal Sympathetic Denervation System
        • Others
      • By Technology:
        • Radiofrequency
        • Ultrasound
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Simplicity Renal Denervation System
        • Vessix Renal denervation System
        • EnligHTN
        • Paradise Renal Denervation System
        • Iberis Renal Sympathetic Denervation System
        • Others
      • By Technology:
        • Radiofrequency
        • Ultrasound
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Simplicity Renal Denervation System
        • Vessix Renal denervation System
        • EnligHTN
        • Paradise Renal Denervation System
        • Iberis Renal sympathetic Denervation System
        • others
      • By Technology:
        • Radiofrequency
        • Ultrasound
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Simplicity Renal Denervation System
        • Vessix Renal denervation System
        • EnligHTN
        • Paradise Renal Denervation System
        • Iberis Renal sympathetic Denervation System
        • Others
      • By Technology:
        • Radiofrequency
        • Ultrasound
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Simplicity Renal Denervation System
        • Vessix Renal denervation System
        • EnligHTN
        • Paradise Renal Denervation System
        • Iberis Renal sympathetic Denervation System
        • Others
      • By Technology:
        • Radiofrequency
        • Ultrasound
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Simplicity Renal Denervation System
        • Vessix Renal denervation System
        • EnligHTN
        • Paradise Renal Denervation System
        • Iberis Renal sympathetic Denervation System
        • Others
      • By Technology:
        • Radiofrequency
        • Ultrasound
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • St. Jude Medical *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • ReCor Medical Inc.
    • Boston Scientific Corporation
    • Cardiosonic Ltd
    • Medtronic Plc.
    • Kona medical, Inc.
    • Mercator Medsystems, Inc.
    • Terumo Corporation
    • Abbott Laboratories
    • Theragenics Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Technology
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Market Trends
    • Impact Analysis
    • Key Highlights
    • PEST Analysis
    • PORTER’s Analysis
    • Mergers and Acquisitions
    • Reimbursement Scenario
    • Regulatory Scenario
    • Epidemiology
  4. Global Renal Denervation Devices Market, By Product Type, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Simplicity Renal Denervation System
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Vessix Renal denervation System
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • EnligHTN
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Paradise Renal Denervation System
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Iberis Renal sympathetic Denervation System
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  5. Global Renal Denervation Devices Market, By Technology, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Radiofrequency
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Ultrasound
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  6. Global Renal Denervation Devices Market, By End User, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  7. Global Renal Denervation Devices Market, By Region, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Germany
        • U.K.
        • France        
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Medtronic Plc*
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • St. Jude Medical
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ReCor Medical Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cardiosonic Ltd.
        •  Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Kona medical, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Mercator Medsystems, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Terumo Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Theragenics Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 36 market data tables and 32 figures on "Renal Denervation Devices Market - Global forecast to 2026”.

Frequently Asked Questions

The global renal denervation devices market is estimated to surpass US$ 1.3 Billion by 2026.
Major players operating in the global renal denervation devices market include St. Jude Medical, Inc., ReCor Medical Inc., Boston Scientific Corporation, Cardiosonic Ltd, Medtronic Plc., Kona Medical, Inc., Mercator Medsystems, Inc., Terumo Corporation, Abbott Laboratories, and Theragenics Corporation.
Adoption of pharmaceutical therapy for the management of hypertension is expected to limit adoption of renal denervation devices. This is one of the major factors that is expected to hamper growth of the market over the forecast period.
Increasing prevalence of cardiovascular diseases (CVDs) and hypertensionis one of the major factors that is expected to propel growth of the market over the forecast period.
The global renal denervation devices market is estimated to exhibit a CAGR of 35.5% over the forecast period (2018-2026).
Among regions, Europe is expected to hold dominant position in the global renal denervation devices market over the forecast period.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner